Background: Hypertrophied myocardium is especially vulnerable to ischemic injury. This study aimed to compare the early and late clinical outcomes of three different methods of myocardial protection in patients with aortic stenosis. Methods: This retrospective study included 225 consecutive patients (mean age, 65±10 years; 123 males) with severe aortic stenosis who underwent aortic valve replacement. Patients were excluded if they had coronary artery disease, an ejection fraction ＜50%, more than mild aortic regurgitation, or endocarditis. The patients were divided into three groups: group A, which was treated with antegrade and retrograde cold blood cardioplegia; group B, which was treated with antegrade crystalloid cardioplegia using histidine-tryptophan-ketoglutarate (HTK) solution; and group C, treated with retrograde cold blood cardioplegia. Results: Group A contained 70 patients (31.1%), group B contained 74 patients (32.9%), and group C contained 81 patients (36%). The three groups showed significant differences with regard to the proportion of patients with a New York Heart Association functional classification ≥III (p=0.035), N-terminal pro-brain natriuretic peptide levels (p=0.042), ejection fraction (p=0.035), left ventricular dimensions (p＜0.001), left ventricular mass index (p＜0.001), and right ventricular systolic pressure (p ＜0.001). Differences in cardiopulmonary bypass time (p=0.532) and aortic cross-clamp time (p=0.48) among the three groups were not statistically significant. During postoperative recovery, no significant differences were found regarding the use of inotropes (p=0.328), mechanical support (n=0), arrhythmias (atrial fibrillation, p=0.347; non-sustained ventricular tachycardia, p=0.1), and ventilator support time (p=0.162). No operative mortality occurred. Similarly, no significant differences were found in long-term outcomes. Conclusion: Although the three groups showed some significant differences with regard to patient characteristics, both antegrade crystalloid cardioplegia with HTK solution and retrograde cold blood cardioplegia led to early and late clinical results similar to those achieved with combined antegrade and retrograde cold blood cardioplegia.
INTRODUCTION
Protecting the myocardium during ischemic cardiac arrest is essential for successful surgical outcomes. Despite extensive experimental and clinical research, it has not been possible to define an optimal method of myocardial protection due to the diverse pathophysiology of diseases whose surgical treatment involves ischemic cardiac arrest and the wide range of surgical situations that may occur. Moreover, most the current literature consists of studies that were conducted to evaluate treatment strategies for coronary artery disease [1] . The results from such studies cannot be directly applied to the treatment of aortic stenosis, because aortic stenosis and coronary artery disease are associated with different metabolic dynamics [2] .
In aortic valve surgery, the antegrade delivery of cardioplegic solution via the aortic root is generally accepted.
However, when aortic regurgitation (AR) occurs, the antegrade method may not be effective. Rapid venting of the left ventricle through a vent catheter or squeezing of the left ventricle during the delivery of cardioplegic solution can be an effective option. Direct coronary ostial cannulation is also possible, but it may result in late coronary ostial stenosis [3] .
Retrograde coronary sinus perfusion of cardioplegic solution may be a promising technique in the presence of significant AR; however, concerns about the efficacy and the safety of this technique with regard to the protection of the right ventricle and the posterior ventricular septum have limited its use [4] .
Previous experimental and clinical studies have shown conflicting results regarding the outcome of retrograde coronary sinus blood cardioplegia. Several studies in the early 1990s suggested that retrograde coronary sinus blood cardioplegia may provide optimal myocardial protection [5] . However, the myocardial protection provided retrograde blood cardioplegia was proven to be inferior to that provided by antegrade blood cardioplegia, based on the assessment of biochemical markers and metabolic responses [5, 6] . The complexity of these results was mostly due to the small numbers of patients studied as well as the heterogeneous techniques and operative procedures employed in these studies [7, 8] . Moreover, previous studies have not demonstrated any differences in clinical outcome when antegrade blood cardioplegia is compared to retrograde cardioplegia or antegrade crystalloid cardioplegia [5] [6] [7] [8] .
This study aimed to compare the clinical efficacy of these three different methods of myocardial protection in the treatment of aortic stenosis. In order to minimize potentially confounding variables, we only included aortic stenosis patients without coronary artery disease, and all patients were operated on and managed by a single surgeon.
METHODS

1) Patients
This retrospective study included 225 consecutive patients who underwent aortic valve replacement performed by a single surgeon from January 1, 2000 to January 1, 2011 in the department of thoracic and cardiovascular surgery at our institution. Patients with severe aortic stenosis were included as the subjects. Patients were excluded if they had coronary artery stenosis (＞50% stenosis in one or more major coronary artery as demonstrated by coronary angiography), an ejection fraction ＜50%, moderate or severe AR, endocarditis, or a history of previous cardiac surgery. Since 2000, our institution's standard protocol for myocardial protection in aortic valve replacement procedures has been either combined antegrade and retrograde cold blood cardioplegia or antegrade crystalloid cardioplegia. In patients with severe aortic stenosis accompanied by mild AR, we prefer retrograde cold blood cardioplegia alone, since direct coronary ostial infusion of the cardioplegic solution may result in early myocardial infarction and late coronary ostial stenosis that causes myocardial ischemia [3] . The subjects were divided into three groups. Group A was treated with antegrade and retrograde cold blood cardioplegia, group B was treated with antegrade crystalloid cardioplegia using histidine-tryptophan-ketoglutarate (HTK) solution, and group C was treated with retrograde cold blood cardioplegia. The clinical records, operation records, and laboratory records of each patient were reviewed. Our institutional review board approved the study protocol and waived the need for consent from patients or relatives due to the retrospective nature of the study.
2) Operative techniques
Consistent anesthetic and operative techniques were used throughout the study period. After median sternotomy, carJung Hee Lee, et al − 166 − diopulmonary bypass (CPB) was established between the ascending aorta and the two individually cannulated venae cavae, which were snared shortly after the onset of bypass. Full systemic heparinization was applied, with an activated clotting time ＞480 seconds. The circuits were primed with 200 mL of albumin, 500 mL of pentastarch, 50 mL/kg of mannitol, 300 mL of plasma solution, 60 mEq of sodium bicarbonate, 500 mg of methylprednisolone, 1 g of MgSO4, 1 g of tranexamic acid, and 300,000 U of ulinastatin. Mild hypothermia was instituted immediately after CPB was initiated. short right atriotomy was performed on the beating heart, and retrograde cardioplegia delivery was performed as described above. As soon as the ascending aorta was cross-clamped, the fibrillator was operated in conjunction with retrograde delivery of cold blood cardioplegia. An aortotomy was then performed to confirm that the cardioplegic solution was draining into the coronary ostia. Maintenance cardioplegic solution was then delivered every 20 to 25 minutes, or whenever there was any evidence of electromechanical activity. The solutions used were identical to those used in group A. Coronary sinus pressure was not measured routinely.
4) Definitions and follow-up
Operative mortality was defined as any postoperative death occurring within 30 days or during the same hospital admission. Low cardiac output syndrome was diagnosed if the patient required an intra-aortic balloon pump in order to be weaned from CPB due to hemodynamic compromise, either in the operating theater or in the intensive care unit. 
5) Statistical analysis
Categorical variables were expressed as frequencies and percentages and compared using the chi-square test or the Fisher's exact test. Continuous variables were presented as mean±standard deviation and compared using unidirectional analysis of variance. Kaplan-Meier curves were used to express overall survival rates. All p-values＜0.05 were considered to indicate statistical significance. IBM SPSS ver. 22.0 (IBM Co., Armonk, NY, USA) was used for statistical analysis.
RESULTS
1) Preoperative characteristics of the patients
The preoperative characteristics of the patients are shown in Table 1 . Patients in group C showed significantly higher N-terminal pro-brain natriuretic peptide levels, higher EuroSCOREs, slightly lower ejection fraction values, larger left ventricular dimensions, and greater left ventricular mass index values. This is consistent with the fact that most of the patients in group C had mild AR (n=64, 79%). Three patients with previous myocardial infarctions (more than three months prior) were included in group B, but they were proven not to have significant coronary artery disease at the time of operation. Otherwise, there were no significant differences between the three groups with regard to preoperative characteristics.
2) Intraoperative data and early outcomes
The intraoperative data showed no significant differences in CPB time (p=0.523) or aortic cross-clamp time (p=0.48) among the three groups (Table 2) . Moreover, no significant differences were observed in post-arrest recovery time (p=0.408), as calculated by subtracting the aortic cross-clamp time from the CPB time (Table 2 ). These findings may partially be due to the fact that we used a fibrillator along with administering cardioplegic solution in order to induce rapid electromechanical quiescence, but we have no direct empirical support.
No statistically significant differences were seen in early postoperative variables (Table 3) . No patients needed mechanical circulatory support after the operation. No differences among the three groups were found in the use of inotropics (p=0.328) or the incidence of arrhythmias (atrial fibrillation, p=0.347; non-sustained ventricular tachycardia, p=0.1). There were no instances of operative mortality.
3) Late outcomes
Clinical follow-up was completed in all patients, with a mean follow-up duration of 70.71±36 months (median, 61.75 months; range, 2 to 163 months). During the follow-up period, 15 late deaths occurred (Table 4) . Six deaths were due to malignancies and three deaths were due to unknown causes.
There were six late cardiac-related deaths: three in group A, two in group B, and one in group C. There were no statistically significant differences in the occurrence of late cardiac-related death (p=0.510). If deaths from unknown causes are regarded as cardiac-related deaths, then five late cardiac-related deaths occurred in group A, two in group B, and two in group C (p=0.27). Kaplan-Meier curves expressing the overall survival rates and freedom from cardiac-related mortality in each group are shown in Fig. 1 and Fig. 2 .
DISCUSSION
It is well known that hypertrophied myocardium is more Jung Hee Lee, et al The ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity. *p-value＜0.05.
vulnerable to ischemic injury [9] . Hypertrophied myocardium presents with dilated epicardial coronary arteries, along with reduced capillary density and vascular dilatation reserve in the subendocardial region [10] . After reperfusion, the myocardium is even more vulnerable to ischemic injury due to the rapid loss of high-energy phosphate, the increased accumulation of lactate and H+, the premature occurrence of ischemic contracture, and accelerated calcium overload [2, 11, 12] .
The above factors may also lead to hypotension and ventricular fibrillation, which can easily develop into subendocardial ischemia and necrosis. Techniques for myocardial protection have mostly been developed and investigated in the clinical setting of coronary bypass surgery [1] . The choice of the optimal myocardial protection technique in patients with hypertrophied myocardium remains controversial [13] . Furthermore, the metabolic differences between hearts with ischemic disease and hypertrophic hearts with aortic valve disease mean that the traditional cardioplegic techniques that were de- Values are presented as number (%).
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Fig. 1.
Kaplan-Meier curves for the overall survival rate. Fig. 2 . Kaplan-Meier curves for freedom from cardiac related mortality.
[ 6, 7, 14, 15] . However, these findings have not so far been confirmed by clinical outcomes. It is difficult to draw reliable conclusions about this issue due to the use of heterogeneous operative procedures, of which the most relevant factors are the wide range of pump times and the variable duration of cardiac arrest [8, 16] . A prospective study comparing blood cardioplegia with crystalloid cardioplegia in patients with isolated aortic stenosis conducted by Ovrum et al. [13] found no difference in the clinical course of the patients. In their study, no statistically significant differences were seen regarding spontaneous sinus rhythm recovery after aortic declamping, the use of inotropic drugs, the duration of ventilator support, the occurrence of perioperative myocardial infarctions, episodes of atrial fibrillation, and mortality. A recent systematic review by Edelman et al. [17] is in agreement with these findings. This review included fourteen studies comparing crystalloid cardioplegia using HTK solution to conventional cardioplegia. Although the majority of studies included assessed the outcomes of coronary bypass graft surgery, no significant difference in mortality rates was found. Ventricular fibrillation was observed to have a higher incidence in the group treated with crystalloid cardioplegia using HTK solution, but this trend did not reach the level of statistical significance.
When AR is associated with aortic stenosis, the antegrade ited its use [4] . Moreover, limited data exist regarding the use of retrograde blood cardioplegia alone in the treatment of aortic stenosis [1, 7] .
In the present study, we compared three different methods of myocardial protection in the treatment of aortic stenosis.
Over time, the strategies used for myocardial protection in patients with aortic stenosis have changed at our institution. In the present study, we found no statistical difference in CPB weaning time among the three groups of patients, and no mechanical circulatory support was required. These results imply that the process of weaning was similar in all groups and suggest that the degree of myocardial damage after early reperfusion was similar, at least from a clinical perspective.
Due to the retrospective design of the present study, no data were collected regarding cardiac rhythm during the CPB weaning process, the release of cardiac markers, and intraoperative measurements of ventricular function during CPB weaning. While our results may not be completely conclusive, they suggest that intraoperative myocardial recovery did not differ among the three groups.
Myocardial damage after reperfusion is also reflected in early postoperative outcomes. During the period of our study, we did not observe any significant perioperative myocardial infarction in procedures treating aortic stenosis. Therefore, the routine surveillance of cardiac biomarkers was not included in operative arrhythmias, and we noted a relatively low incidence compared to previous studies [1, 7, 8, 13, 16] . Surprisingly, no operative mortality was observed among the three groups.
Moreover, no statistically significant differences were found among the three groups regarding other parameters that reflect early postoperative outcomes, such as ventilator support, duration of stay in the intensive care unit, and duration of stay in the hospital. These findings are in agreement with previous studies [6] [7] [8] 13, 16, 17] . As well, no significant differences were found regarding long-term mortality. The
Kaplan-Maier survival curves of overall mortality ( Fig. 1 ) and freedom from cardiac related mortality (Fig. 2) showed no statistical significance. Further study is needed to confirm these conclusions.
The study has some potential limitations. First, some significant differences were found among the three groups regarding preoperative patient characteristics. The mean age of patients in groups B and C was higher than that of patients in group A. Group B included significantly fewer New York Heart Association III or IV patients compared to group C, ac- 
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